Autopsy report · NCT05730556
A Study of Remote Electrical Neuromodulation for Acute Procedural Pain
Cause of deathOther
“Enough data was collected to demonstrate device efficacy at interim analysis”
Life of this trial
- Ran for about 1 year 7 months before it stopped.
- 80 participants enrolled.
- Results were posted on the registry 1 year 2 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- Mayo Clinic
- Sponsor type
- University, hospital or other
- Conditions
- Chronic Migraine
- Interventions
- Nerivio ®; Sham
- Participants
- 80
- Sites
- 1
- Countries
- United States
Trials that died the same way
- A Study to Assess the Anti-fatigability Effect of CK-2127107 in Elderly Male and Female Subjects With Limitations in Mobility
“Lack of efficacy determined at interim analysis” - Evaluation of Directional Recording and Stimulation Using spiderSTN
“This study was structured in 2 phases, and was stopped after the first phase. The collected data will be used to improve the device and prepare future studies.” - Evaluation of Performance and Safety of Carbopol 980 NF 0.2%- Based Medical Device in the Management of Patients With Glaucomar or Ocular Hypertension and Concomitant Dry Eye Syndrome on Multiple Long-term Topical Hypotensive Therapy
“The investigation was prematurely interrupted with 65 patients enrolled due to difficulties in recruiting patients. However the results observed in the interim analysis demonstrate the performance of the investigational device.” - LBH589 in Refractory Myelodysplastic Syndromes (MDS)
“Per protocol, the results of a planned interim analysis demonstrated insufficient efficacy and led to early termination of the study.” - An in Vivo Comparison of the Debridement Efficiency of Needle Irrigation Versus Ultrasonic Irrigation
“Manufacturer changed device so no study will be done; ie it was never started”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.